Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P McBurney

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Vaccine|April 25, 2009
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccinesSean P McBurney, Ted M Ross
Current Pharmaceutical Design|July 14, 2007
Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccinesSean P McBurney, Ted M Ross
Expert Review of Vaccines|November 5, 2008
Viral sequence diversity: challenges for AIDS vaccine designsSean P McBurney, Ted M Ross
Virology|October 3, 2006
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopesSean P McBurney, Kelly R Young, Ted M Ross
AIDS Research and Human Retroviruses|January 5, 2012
Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccineSean P McBurney, Gary Landucci, Donald N Forthal, et al.
Methods (San Diego, Calif.)|September 26, 2006
Virus-like particles: designing an effective AIDS vaccineKelly R Young, Sean P McBurney, Lukena U Karkhanis, et al.
Current HIV Research|November 1, 2006
Lentivirus-like particles without reverse transcriptase elicit efficient immune responsesSean P McBurney, Kelly R Young, Casmiar I Nwaigwe, et al.
Vaccine|April 17, 2016
Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primatesSean P McBurney, Justine E Sunshine, Sarah Gabriel, et al.
BMC Microbiology|July 17, 2016
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cellsMaria Trovato, Francesco Maurano, Luciana D'Apice, et al.
Journal of Virology|March 9, 2018
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus ChallengesAnn J Hessell, Mariya B Shapiro, Rebecca Powell, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Vaccine|April 25, 2009
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccinesSean P McBurney, Ted M Ross
Current Pharmaceutical Design|July 14, 2007
Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccinesSean P McBurney, Ted M Ross
Expert Review of Vaccines|November 5, 2008
Viral sequence diversity: challenges for AIDS vaccine designsSean P McBurney, Ted M Ross
Virology|October 3, 2006
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopesSean P McBurney, Kelly R Young, Ted M Ross
AIDS Research and Human Retroviruses|January 5, 2012
Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccineSean P McBurney, Gary Landucci, Donald N Forthal, et al.
Methods (San Diego, Calif.)|September 26, 2006
Virus-like particles: designing an effective AIDS vaccineKelly R Young, Sean P McBurney, Lukena U Karkhanis, et al.
Current HIV Research|November 1, 2006
Lentivirus-like particles without reverse transcriptase elicit efficient immune responsesSean P McBurney, Kelly R Young, Casmiar I Nwaigwe, et al.
Vaccine|April 17, 2016
Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primatesSean P McBurney, Justine E Sunshine, Sarah Gabriel, et al.
BMC Microbiology|July 17, 2016
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cellsMaria Trovato, Francesco Maurano, Luciana D'Apice, et al.
Journal of Virology|March 9, 2018
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus ChallengesAnn J Hessell, Mariya B Shapiro, Rebecca Powell, et al.
Pageof 2